nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Methotrexate—bone cancer	0.297	0.429	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—bone cancer	0.173	0.249	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—bone cancer	0.12	0.174	CbGbCtD
Ceftriaxone—ALB—Methotrexate—bone cancer	0.102	0.148	CbGbCtD
Ceftriaxone—Alveolitis allergic—Methotrexate—bone cancer	0.00652	0.0212	CcSEcCtD
Ceftriaxone—Secondary infection—Epirubicin—bone cancer	0.00542	0.0176	CcSEcCtD
Ceftriaxone—Nephropathy toxic—Cisplatin—bone cancer	0.0054	0.0176	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Cisplatin—bone cancer	0.00504	0.0164	CcSEcCtD
Ceftriaxone—Secondary infection—Doxorubicin—bone cancer	0.00502	0.0163	CcSEcCtD
Ceftriaxone—Warmth—Epirubicin—bone cancer	0.00501	0.0163	CcSEcCtD
Ceftriaxone—Warmth—Doxorubicin—bone cancer	0.00464	0.0151	CcSEcCtD
Ceftriaxone—Haematocrit decreased—Methotrexate—bone cancer	0.00457	0.0149	CcSEcCtD
Ceftriaxone—Infection—Carboplatin—bone cancer	0.00375	0.0122	CcSEcCtD
Ceftriaxone—Tenderness—Cisplatin—bone cancer	0.00356	0.0116	CcSEcCtD
Ceftriaxone—Pain—Carboplatin—bone cancer	0.00323	0.0105	CcSEcCtD
Ceftriaxone—Lymphopenia—Epirubicin—bone cancer	0.00311	0.0101	CcSEcCtD
Ceftriaxone—Lactic dehydrogenase activity increased—Epirubicin—bone cancer	0.00311	0.0101	CcSEcCtD
Ceftriaxone—Body temperature increased—Carboplatin—bone cancer	0.00298	0.0097	CcSEcCtD
Ceftriaxone—Lactic dehydrogenase activity increased—Doxorubicin—bone cancer	0.00288	0.00937	CcSEcCtD
Ceftriaxone—Lymphopenia—Doxorubicin—bone cancer	0.00288	0.00937	CcSEcCtD
Ceftriaxone—Local reaction—Epirubicin—bone cancer	0.00288	0.00936	CcSEcCtD
Ceftriaxone—Blood lactate dehydrogenase increased—Epirubicin—bone cancer	0.00274	0.00892	CcSEcCtD
Ceftriaxone—Local reaction—Doxorubicin—bone cancer	0.00266	0.00866	CcSEcCtD
Ceftriaxone—Phlebitis—Cisplatin—bone cancer	0.00261	0.0085	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Epirubicin—bone cancer	0.00259	0.00843	CcSEcCtD
Ceftriaxone—Thrombocytosis—Epirubicin—bone cancer	0.00256	0.00833	CcSEcCtD
Ceftriaxone—Blood lactate dehydrogenase increased—Doxorubicin—bone cancer	0.00254	0.00825	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Cisplatin—bone cancer	0.00249	0.00811	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Doxorubicin—bone cancer	0.0024	0.0078	CcSEcCtD
Ceftriaxone—Thrombocytosis—Doxorubicin—bone cancer	0.00237	0.00771	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Cisplatin—bone cancer	0.00233	0.00757	CcSEcCtD
Ceftriaxone—Fungal infection—Methotrexate—bone cancer	0.0022	0.00717	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Epirubicin—bone cancer	0.00215	0.007	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Cisplatin—bone cancer	0.00211	0.00686	CcSEcCtD
Ceftriaxone—Fungal infection—Epirubicin—bone cancer	0.00206	0.00671	CcSEcCtD
Ceftriaxone—Feeling hot—Epirubicin—bone cancer	0.00203	0.0066	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.00203	0.0066	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Doxorubicin—bone cancer	0.00199	0.00648	CcSEcCtD
Ceftriaxone—Glycosuria—Epirubicin—bone cancer	0.00197	0.0064	CcSEcCtD
Ceftriaxone—Proteinuria—Methotrexate—bone cancer	0.00194	0.0063	CcSEcCtD
Ceftriaxone—Protein urine present—Methotrexate—bone cancer	0.00191	0.00622	CcSEcCtD
Ceftriaxone—Fungal infection—Doxorubicin—bone cancer	0.00191	0.00621	CcSEcCtD
Ceftriaxone—Pancreatitis—Cisplatin—bone cancer	0.00191	0.00621	CcSEcCtD
Ceftriaxone—Sweating increased—Cisplatin—bone cancer	0.0019	0.00617	CcSEcCtD
Ceftriaxone—Feeling hot—Doxorubicin—bone cancer	0.00188	0.00611	CcSEcCtD
Ceftriaxone—Glossitis—Methotrexate—bone cancer	0.00185	0.00601	CcSEcCtD
Ceftriaxone—Oliguria—Methotrexate—bone cancer	0.00185	0.00601	CcSEcCtD
Ceftriaxone—Glycosuria—Doxorubicin—bone cancer	0.00182	0.00592	CcSEcCtD
Ceftriaxone—Oliguria—Epirubicin—bone cancer	0.00173	0.00562	CcSEcCtD
Ceftriaxone—Glossitis—Epirubicin—bone cancer	0.00173	0.00562	CcSEcCtD
Ceftriaxone—Renal failure—Cisplatin—bone cancer	0.00171	0.00555	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Methotrexate—bone cancer	0.0017	0.00554	CcSEcCtD
Ceftriaxone—Stomatitis—Cisplatin—bone cancer	0.00169	0.0055	CcSEcCtD
Ceftriaxone—Vaginal infection—Methotrexate—bone cancer	0.00161	0.00523	CcSEcCtD
Ceftriaxone—Oliguria—Doxorubicin—bone cancer	0.0016	0.0052	CcSEcCtD
Ceftriaxone—Glossitis—Doxorubicin—bone cancer	0.0016	0.0052	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Methotrexate—bone cancer	0.0016	0.0052	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Epirubicin—bone cancer	0.00159	0.00518	CcSEcCtD
Ceftriaxone—Colitis—Epirubicin—bone cancer	0.00153	0.00498	CcSEcCtD
Ceftriaxone—Candida infection—Epirubicin—bone cancer	0.00152	0.00495	CcSEcCtD
Ceftriaxone—Vaginal infection—Epirubicin—bone cancer	0.0015	0.00489	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Epirubicin—bone cancer	0.0015	0.00487	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Doxorubicin—bone cancer	0.00147	0.0048	CcSEcCtD
Ceftriaxone—Flushing—Cisplatin—bone cancer	0.00145	0.0047	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methotrexate—bone cancer	0.00143	0.00464	CcSEcCtD
Ceftriaxone—Colitis—Doxorubicin—bone cancer	0.00142	0.0046	CcSEcCtD
Ceftriaxone—Candida infection—Doxorubicin—bone cancer	0.00141	0.00458	CcSEcCtD
Ceftriaxone—Hypertonia—Epirubicin—bone cancer	0.0014	0.00454	CcSEcCtD
Ceftriaxone—Vaginal infection—Doxorubicin—bone cancer	0.00139	0.00453	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Doxorubicin—bone cancer	0.00138	0.0045	CcSEcCtD
Ceftriaxone—Phlebitis—Epirubicin—bone cancer	0.00134	0.00437	CcSEcCtD
Ceftriaxone—Flatulence—Cisplatin—bone cancer	0.00134	0.00435	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Epirubicin—bone cancer	0.00134	0.00435	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—bone cancer	0.00132	0.0043	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—bone cancer	0.00131	0.00426	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—bone cancer	0.00129	0.0042	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—bone cancer	0.00128	0.00415	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Cisplatin—bone cancer	0.00126	0.00409	CcSEcCtD
Ceftriaxone—Anaemia—Cisplatin—bone cancer	0.00125	0.00408	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—bone cancer	0.00124	0.00404	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—bone cancer	0.00124	0.00402	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—bone cancer	0.00123	0.00399	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—bone cancer	0.00122	0.00398	CcSEcCtD
Ceftriaxone—Malaise—Cisplatin—bone cancer	0.00122	0.00398	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—bone cancer	0.00122	0.00395	CcSEcCtD
Ceftriaxone—Leukopenia—Cisplatin—bone cancer	0.00121	0.00395	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—bone cancer	0.00119	0.00389	CcSEcCtD
Ceftriaxone—Convulsion—Cisplatin—bone cancer	0.00118	0.00382	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—bone cancer	0.00116	0.00378	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—bone cancer	0.00114	0.00371	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00113	0.00369	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—bone cancer	0.00112	0.00366	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00111	0.00362	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—bone cancer	0.00111	0.0036	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—bone cancer	0.00111	0.0036	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00111	0.0036	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—bone cancer	0.0011	0.00358	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—bone cancer	0.00109	0.00354	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—bone cancer	0.00108	0.00353	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—bone cancer	0.00108	0.00352	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—bone cancer	0.00107	0.00348	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—bone cancer	0.00106	0.00344	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—bone cancer	0.00106	0.00344	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—bone cancer	0.00105	0.00341	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00104	0.00339	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00104	0.00339	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—bone cancer	0.00101	0.00327	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—bone cancer	0.001	0.00326	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—bone cancer	0.000999	0.00325	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—bone cancer	0.000994	0.00323	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—bone cancer	0.00099	0.00322	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—bone cancer	0.00098	0.00319	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—bone cancer	0.000977	0.00318	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000964	0.00313	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000964	0.00313	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—bone cancer	0.000947	0.00308	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000944	0.00307	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—bone cancer	0.000936	0.00305	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—bone cancer	0.000935	0.00304	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—bone cancer	0.000928	0.00302	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—bone cancer	0.000916	0.00298	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—bone cancer	0.000912	0.00297	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—bone cancer	0.000908	0.00295	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—bone cancer	0.000907	0.00295	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—bone cancer	0.000898	0.00292	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—bone cancer	0.000889	0.00289	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000884	0.00287	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—bone cancer	0.000876	0.00285	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—bone cancer	0.000875	0.00285	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—bone cancer	0.000869	0.00283	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—bone cancer	0.000869	0.00283	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—bone cancer	0.000865	0.00281	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—bone cancer	0.000859	0.0028	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—bone cancer	0.000855	0.00278	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—bone cancer	0.00085	0.00276	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—bone cancer	0.000841	0.00273	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—bone cancer	0.000832	0.00271	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000818	0.00266	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—bone cancer	0.000816	0.00265	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—bone cancer	0.000811	0.00264	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—bone cancer	0.000808	0.00263	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—bone cancer	0.000804	0.00262	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—bone cancer	0.000804	0.00261	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—bone cancer	0.000804	0.00261	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—bone cancer	0.0008	0.0026	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—bone cancer	0.000786	0.00256	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—bone cancer	0.000778	0.00253	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—bone cancer	0.00077	0.0025	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—bone cancer	0.000767	0.0025	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—bone cancer	0.000757	0.00246	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—bone cancer	0.000756	0.00246	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—bone cancer	0.000744	0.00242	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—bone cancer	0.000743	0.00242	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—bone cancer	0.00074	0.00241	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—bone cancer	0.000729	0.00237	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—bone cancer	0.000718	0.00234	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—bone cancer	0.000704	0.00229	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—bone cancer	0.0007	0.00228	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—bone cancer	0.000698	0.00227	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—bone cancer	0.000697	0.00227	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—bone cancer	0.000691	0.00225	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—bone cancer	0.000688	0.00224	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—bone cancer	0.000687	0.00223	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—bone cancer	0.000686	0.00223	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—bone cancer	0.000682	0.00222	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—bone cancer	0.000671	0.00218	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—bone cancer	0.000666	0.00217	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—bone cancer	0.000664	0.00216	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—bone cancer	0.000657	0.00214	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—bone cancer	0.000646	0.0021	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—bone cancer	0.000645	0.0021	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—bone cancer	0.000644	0.00209	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—bone cancer	0.00064	0.00208	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—bone cancer	0.000635	0.00207	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—bone cancer	0.000631	0.00205	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—bone cancer	0.000628	0.00204	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—bone cancer	0.000626	0.00204	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—bone cancer	0.000623	0.00203	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—bone cancer	0.000615	0.002	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—bone cancer	0.000607	0.00198	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—bone cancer	0.000603	0.00196	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—bone cancer	0.000603	0.00196	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—bone cancer	0.000598	0.00194	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—bone cancer	0.000596	0.00194	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—bone cancer	0.000595	0.00193	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—bone cancer	0.000592	0.00193	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—bone cancer	0.000587	0.00191	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—bone cancer	0.000586	0.00191	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—bone cancer	0.000581	0.00189	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—bone cancer	0.000577	0.00188	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—bone cancer	0.00057	0.00185	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—bone cancer	0.000568	0.00185	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—bone cancer	0.000568	0.00185	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—bone cancer	0.000565	0.00184	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—bone cancer	0.000558	0.00182	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—bone cancer	0.000557	0.00181	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—bone cancer	0.00055	0.00179	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—bone cancer	0.000545	0.00177	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—bone cancer	0.000542	0.00176	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—bone cancer	0.000535	0.00174	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—bone cancer	0.000526	0.00171	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—bone cancer	0.000526	0.00171	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—bone cancer	0.000523	0.0017	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—bone cancer	0.000519	0.00169	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—bone cancer	0.000515	0.00168	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—bone cancer	0.00051	0.00166	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—bone cancer	0.000508	0.00165	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—bone cancer	0.000501	0.00163	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—bone cancer	0.0005	0.00163	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—bone cancer	0.000497	0.00162	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—bone cancer	0.000486	0.00158	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—bone cancer	0.000483	0.00157	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—bone cancer	0.00048	0.00156	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—bone cancer	0.00048	0.00156	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—bone cancer	0.000472	0.00154	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—bone cancer	0.000468	0.00152	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—bone cancer	0.000465	0.00151	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—bone cancer	0.000463	0.00151	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—bone cancer	0.000452	0.00147	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—bone cancer	0.00045	0.00146	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—bone cancer	0.000449	0.00146	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—bone cancer	0.000449	0.00146	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—bone cancer	0.000448	0.00146	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—bone cancer	0.000433	0.00141	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—bone cancer	0.00043	0.0014	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—bone cancer	0.00043	0.0014	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—bone cancer	0.000419	0.00136	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—bone cancer	0.000418	0.00136	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—bone cancer	0.000416	0.00135	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—bone cancer	0.000416	0.00135	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—bone cancer	0.000416	0.00135	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—bone cancer	0.000402	0.00131	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—bone cancer	0.000402	0.00131	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—bone cancer	0.000389	0.00127	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—bone cancer	0.000388	0.00126	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—bone cancer	0.000386	0.00126	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—bone cancer	0.000383	0.00125	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—bone cancer	0.000383	0.00124	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—bone cancer	0.000381	0.00124	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—bone cancer	0.000376	0.00122	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—bone cancer	0.000372	0.00121	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—bone cancer	0.000361	0.00118	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—bone cancer	0.000361	0.00117	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—bone cancer	0.00036	0.00117	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—bone cancer	0.000358	0.00117	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—bone cancer	0.000358	0.00116	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—bone cancer	0.000356	0.00116	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—bone cancer	0.000348	0.00113	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—bone cancer	0.000338	0.0011	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—bone cancer	0.000334	0.00109	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—bone cancer	0.000332	0.00108	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—bone cancer	0.000331	0.00108	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—bone cancer	0.000329	0.00107	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—bone cancer	0.000312	0.00102	CcSEcCtD
